Study guide

6.3 Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional)

Certified Ambulatory Surgery Nurse CNAMB

Track your progress as you read

Finished sections get a check mark.

1 CNAMB Exam Blueprint, Eligibility & Test Strategy

Current CNAMB Exam Facts, Eligibility & Blueprint

2 Chapter 1: Preoperative Health Assessment & Diagnostic Evaluation

1.1 Patient Health History, Physical Assessment & Medication Reconciliation 1.2 Laboratory, Diagnostic & Cardiac Data Review in Ambulatory Surgery 1.3 Allergy Screening, Sensitivity Identification & Latex Precautions

3 Chapter 2: Risk Stratification, Anesthesia Screening & Pre-Op Clearance

2.1 ASA Physical Status Classification & ASC Patient Candidacy Criteria 2.2 Obstructive Sleep Apnea, Cardiovascular & Metabolic Risk Stratification

4 Chapter 3: Ambulatory Surgical Care Planning & Infection Prophylaxis

3.1 Perioperative Nursing Diagnoses & Individualized Ambulatory Care Plans 3.2 Surgical Site Infection (SSI) Prevention Bundles & Prophylactic Antibiotic Timing

5 Chapter 4: Patient Education, Vulnerable Populations & Discharge Prep

4.1 Preoperative Patient & Escort Education, Fasting Guidelines & NPO Rules 4.2 Health Literacy, Language Access & Cultural/Spiritual Care 4.3 Pediatric & Geriatric Ambulatory Care

6 Chapter 5: Surgical Asepsis, Sterile Technique & OR Environment

5.1 Principles of Surgical Asepsis, Sterile Field Integrity & Traffic Control 5.2 Surgical Hand Antisepsis, Gowning, Gloving & Draping Standards 5.3 Ambulatory OR Environmental Controls: HVAC, Temperature, Humidity & Air Exchanges

7 Chapter 6: Patient Positioning, Equipment Safety & Intraoperative Monitoring

6.1 Surgical Positioning: Alignment, Pressure Injury Prevention & Nerve Protection 6.2 Safe Use of Electrosurgery Units (ESU), Surgical Lasers & Smoke Evacuation 6.3 Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional) 6.4 Surgical Counts, Specimen Management Protocols & Wound Classification 6.5 Intraoperative Medication, Solution & Fluid Safety 6.6 Implants, Explants, Radiation & Hazardous Materials

8 Chapter 7: Interdisciplinary Communication & Handoff Protocols

7.1 Structured Handoff Protocols: SBAR, IPASS & Care Transitions in the ASC 7.2 Universal Protocol, Time-Out Verification & Wrong-Site Surgery Prevention

9 Chapter 8: Clinical Documentation, Electronic Health Records & Informed Consent

8.1 Ambulatory Nursing Documentation Standards, Timelines & Legal Integrity 8.2 Informed Consent Verification, Patient Autonomy & Refusal of Care

10 Chapter 9: Phase I Postanesthesia Care & Complication Management

9.1 Phase I PACU Airway Management, Oxygenation & Hemodynamic Stabilization 9.2 Postoperative Pain Management & PONV Multimodal Protocols in the ASC 9.3 Emergent Postoperative Complications: Laryngospasm, Hemorrhage & Hypothermia

11 Chapter 10: Phase II Recovery, Discharge Criteria & Post-Discharge Safety

10.1 Aldrete Scoring, PADSS (Post-Anesthesia Discharge Scoring System) & Discharge Readiness 10.2 Patient & Escort Discharge Instructions, Home Care & Follow-Up

12 Chapter 11: Instrument Processing, Sterilization & Supply Management

11.1 Point-of-Use Treatment, Decontamination & Cleaning of Surgical Instruments 11.2 High-Level Disinfection, Steam Sterilization & Low-Temperature Methods 11.3 Sterilization Process Monitoring: Chemical/Biological Indicators & Sterile Storage

13 Chapter 12: Ambulatory Perioperative Emergencies

12.1 Malignant Hyperthermia: Presentation, Ryanodex/Dantrolene Protocol & ASC Preparedness 12.2 Local Anesthetic Systemic Toxicity (LAST): Recognition, Lipid Emulsion & Resuscitation 12.3 Surgical Suite Fires, Code Blue & Emergency Transfer/Evacuation in the ASC 12.4 Anaphylaxis, Hemorrhage, Age-Specific Arrest & Disaster Response

14 Chapter 13: Management of Personnel, Services, and Materials

13.1 ASC Staffing Models, Competency Verification & Rapid Turnover Coordination 13.2 Inventory Management, Surgeon Preference Cards & Cost-Containment Strategies 13.3 Medical Device Safety, Preventive Maintenance & Vendor Management 13.4 Product Evaluation, Recalls, PPE & Environmental Stewardship

15 Chapter 14: Legal Standards, Regulatory Framework & Professional Ethics

14.1 Nursing Scope of Practice, UAP Delegation & ANA/AORN Professional Standards 14.2 Ethics in Ambulatory Care: Patient Advocacy, Confidentiality (HIPAA) & Mandatory Reporting 14.3 Competence, Bias, Civility & Evidence-Based Practice

16 Chapter 15: Quality Improvement, Accreditation & Evidence-Based Practice

15.1 ASC Accreditation Standards: AAAHC, The Joint Commission & CMS Conditions for Coverage 15.2 Quality Improvement, Infection Surveillance (NHSN), Incident Reporting & Root Cause Analysis 15.3 Certification Value, Professional Growth & Lifelong Learning (CCI CNAMB Maintenance)

6.3 Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional)

Key Takeaways Explain This Topic AI

The continuum of sedation spans minimal sedation (anxiolysis), moderate sedation (conscious sedation), deep sedation, and general anesthesia; patients can rapidly slip into deeper unintended levels of sedation, necessitating continuous airway and ventilatory vigilance.

ASA standard monitoring mandates continuous ECG, pulse oximetry, noninvasive blood pressure at least every 5 minutes, core temperature monitoring for procedures >30 minutes or under general anesthesia, and continuous quantitative capnography (EtCO2) for all moderate/deep sedation and general anesthesia.

Monitored Anesthesia Care (MAC) is an anesthesia service provided by a qualified anesthesia professional that includes clinical assessment and hemodynamic management, with immediate readiness to convert to general anesthesia.

Local Anesthetic Systemic Toxicity (LAST) is a life-threatening complication characterized by initial neuroexcitation (tinnitus, metallic taste, seizures) followed by cardiovascular collapse; immediate treatment mandates stopping local anesthetic and infusing 20% Lipid Emulsion (Intralipid).

Pneumatic tourniquet safety requires setting inflation pressure relative to Limb Occlusion Pressure (arm: 50-75 mmHg above SBP; leg: 100-150 mmHg above SBP), adhering to a maximum inflation duration of 90-120 minutes, and monitoring sedation reversal agents (naloxone, flumazenil) for rebound resedation.

Last updated: September 2026

Intraoperative Patient Monitoring & Anesthesia Assist (MAC, General, Regional)

Core Principle: In ambulatory surgery centers, patient turnover is rapid, and diverse anesthetic modalities—ranging from nurse-administered procedural sedation to complex peripheral nerve blocks, Monitored Anesthesia Care (MAC), and general anesthesia—are performed daily. The perioperative registered nurse must possess expert knowledge of physiological monitoring standards, airway dynamics, regional block management, toxicological emergency rescues (such as LAST), and pharmacodynamic reversal kinetics to ensure patient survival during intraoperative deterioration.

The Continuum of Sedation & ASA Classifications

The American Society of Anesthesiologists (ASA) defines sedation as a dynamic, unpredictable continuum rather than distinct, rigid states. A patient administered moderate sedation can easily drift into deep sedation or general anesthesia with loss of protective airway reflexes.

Sedation Level Responsiveness & Cognition Airway Patency Spontaneous Ventilation Cardiovascular Function

Minimal Sedation (Anxiolysis) Normal response to verbal commands; cognitive function and physical coordination may be impaired. Unaffected; patient maintains airway independently. Unaffected; normal minute ventilation. Unaffected; resting hemodynamics baseline.

Moderate Sedation / Conscious Sedation Purposeful response to verbal commands alone or accompanied by light tactile stimulation (reflex withdrawal to pain is NOT purposeful). No intervention required; patient maintains a patent airway independently. Adequate; spontaneous ventilation is maintained without assistance. Usually maintained; blood pressure and heart rate remain stable within normal limits.

Deep Sedation Purposeful response only after repeated or painful stimulation ; patient cannot be easily aroused. Intervention may be required ; pharyngeal muscle tone relaxes, risking partial/complete airway obstruction. May be inadequate ; hypoventilation, hypercarbia, and hypoxemia can develop rapidly. Usually maintained; minor drops in systemic vascular resistance or heart rate may occur.

General Anesthesia Unarousable , even with painful, noxious surgical stimulation; complete loss of consciousness. Intervention frequently required ; endotracheal intubation, supraglottic airway (LMA), or oral/nasal airway necessary. Frequently inadequate or absent; requires mechanical positive-pressure ventilation. Frequently impaired ; volatile agents and IV inductors induce myocardial depression and vasodilation.

ASA Standards for Basic Anesthetic Monitoring

The ASA establishes two fundamental standards of care applicable to all patients receiving general anesthesia, regional anesthesia, or Monitored Anesthesia Care (MAC):

Standard I: Dedicated Qualified Personnel

Qualified anesthesia personnel (anesthesiologist or certified registered nurse anesthetist [CRNA]) must be present in the room throughout the conduct of all general anesthetics, regional anesthetics, and monitored anesthesia care. If an emergency requires temporary absence, a qualified individual must be designated to maintain continuous patient observation.

Standard II: Continuous Physiological Monitoring

During all anesthetics, the patient's oxygenation, ventilation, circulation, and temperature must be continuously evaluated:

Oxygenation:

Continuous pulse oximetry (SpO₂) with an audible pulse tone and variable pitch proportional to oxygen saturation must be operational at all times.

Adequate illumination and exposure of the patient to assess skin color, nail beds, and surgical field blood color.

Ventilation:

Continuous Quantitative Capnography (End-Tidal CO₂ [EtCO₂]): Mandatory for all patients undergoing general anesthesia, moderate sedation, or deep sedation. Capnography must monitor expired carbon dioxide continuously from initiation until discharge from the anesthetizing location.

Clinical Significance: Pulse oximetry detects hypoxemia only after alveolar oxygen reserves are depleted—a delay of up to 2 to 5 minutes in a pre-oxygenated patient. Capnography detects hypoventilation, airway obstruction, laryngospasm, apnea, or accidental extubation instantaneously (within 1 to 2 breath cycles).

Circulation:

Continuous display of the electrocardiogram (ECG) from the beginning of anesthesia until departure.

Determination and recording of arterial blood pressure and heart rate at least every 5 minutes .

Body Temperature:

Core body temperature must be monitored whenever clinically significant changes in temperature are anticipated, intended, or suspected (e.g., procedures lasting >30 minutes , pediatric patients, or general anesthesia).

Active forced-air warming blankets should be initiated preoperatively and maintained intraoperatively to keep core temperature ≥36.0°C (96.8°F) , preventing hypothermia-induced coagulopathy, surgical site infections, and delayed PACU discharge.

Monitored Anesthesia Care (MAC) & Circulator Responsibilities

Monitored Anesthesia Care (MAC) is an active anesthesia service provided by a qualified anesthesia professional for a diagnostic or therapeutic procedure. It is distinct from nurse-administered procedural sedation:

Scope of MAC: MAC includes pre-procedure assessment, intraoperative administration of sedative-hypnotics, analgesics, and anxiolytics titrated to patient tolerance, continuous monitoring of vital signs, and hemodynamic management. Crucially, the provider must be prepared at any moment to convert the case to general anesthesia (including endotracheal intubation) if airway compromise, agitation, or severe surgical pain occurs.

Circulating Nurse Role During MAC:

Maintain an environment of minimal sensory stimulation (reduce ambient noise and harsh lighting during induction).

Keep suction canisters connected, turned on, and tested at the bedside with a rigid tonsillar suction tip (Yankauer) ready for instant use.

Ensure emergency airway equipment (bag-valve-mask, oral/nasal airways, video laryngoscope, endotracheal tubes) and emergency resuscitation medications (epinephrine, atropine, succinylcholine) are immediately accessible.

Continuously observe chest wall excursion, respiratory rate, and patient comfort in coordination with the anesthesia provider.

Regional Anesthesia Support & Local Anesthetic Systemic Toxicity (LAST)

Regional anesthesia techniques—including peripheral nerve blocks (interscalene, supraclavicular, femoral, adductor canal, popliteal) and neuraxial anesthesia (spinal, epidural)—are cornerstones of ambulatory surgery, providing superior postoperative analgesia and decreasing opioid requirements.

Intravenous Regional Anesthesia (Bier Block)

Indicated for short soft-tissue or orthopedic procedures of the forearm and hand (lasting <60 minutes).

The extremity is exsanguinated using an Esmarch bandage, followed by inflation of a double-pneumatic tourniquet .

Intravenous lidocaine (typically 0.5% preservative-free, without epinephrine ) is injected into a distal cannula.

Critical 20-Minute Safety Rule: The tourniquet must never be deflated in less than 20 to 30 minutes from the time of local anesthetic injection, regardless of how quickly the surgeon finishes. Premature deflation releases a massive bolus of unbound lidocaine directly into the systemic circulation, precipitating acute seizure activity and cardiac arrest.

Tourniquet Pain Management: After 30 to 45 minutes, ischemic tourniquet pain develops. The circulator assists by inflating the distal cuff (which sits over anesthetized tissue) and subsequently deflating the proximal cuff.

Neuraxial Block Assessment (Spinal vs. Epidural)

The nurse assesses sensory dermatome levels using a cold alcohol sponge or blunt pinprick:

T4 Level: Nipple line (required for Cesarean section or upper abdominal surgery).

T6 Level: Xiphoid process (lower abdominal procedures).

T10 Level: Umbilicus (gynecologic, inguinal hernia, cystoscopy).

L1 Level: Inguinal ligament / groin.

High Spinal Complication: If local anesthetic tracks cephalad, blocking cardioaccelerator sympathetic fibers (originating from T1 to T4 ), the patient develops severe, life-threatening profound hypotension and bradycardia . If the block reaches C3-C5 (phrenic nerve), diaphragmatic paralysis and respiratory arrest ensue.

Local Anesthetic Systemic Toxicity (LAST) Protocol

Local Anesthetic Systemic Toxicity (LAST) occurs secondary to accidental direct intravascular injection or rapid systemic absorption of high doses of local anesthetics (e.g., bupivacaine, ropivacaine, lidocaine). Long-acting lipophilic amino-amides (especially bupivacaine ) bind tightly to cardiac sodium channels, making resuscitation notoriously difficult. ┌────────────────────────────────────────────────────────────────────────┐

  • │ PROGRESSION OF LOCAL ANESTHETIC SYSTEMIC TOXICITY (LAST) │
  • ├────────────────────────────────────────────────────────────────────────┤
  • │ 1. EARLY CNS EXCITATION (Initial Warning Signs) │
  • │ ↳ Metallic taste in mouth, circumoral numbness, tinnitus, dizziness │
  • │ ↳ Visual disturbances, agitation, confusion, pressured speech │
  • │ │
  • │ 2. ADVANCED CNS DEPRESSION │
  • │ ↳ Muscle twitching, facial tremors, generalized tonic-clonic seizure │
  • │ ↳ Unconsciousness, coma, central respiratory arrest │
  • │ │
  • │ 3. CARDIOVASCULAR COLLAPSE (Can Occur Simultaneously with Bupivacaine) │
  • │ ↳ Severe refractory hypotension, conduction heart blocks, bradycardia│
  • │ ↳ Ventricular tachycardia, ventricular fibrillation, asystole │
  • └────────────────────────────────────────────────────────────────────────┘
  • ASRA Treatment Protocol for LAST: 20% Lipid Emulsion Rescue

Immediate Cessation & Call for Help: Immediately halt local anesthetic injection. Shout for the LAST Rescue Kit and emergency cardiac arrest team.

Airway & Ventilation: Ventilate with 100% oxygen . Hyperventilation helps prevent acidosis and hypercarbia, which exacerbate local anesthetic binding to myocardial receptors.

Seizure Suppression: Administer small IV doses of benzodiazepines (midazolam 1–2 mg) . Avoid propofol in hemodynamically unstable patients due to severe cardiodepressant effects.

20% Lipid Emulsion (Intralipid) Administration:

Acts as a "lipid sink," extracting lipophilic local anesthetic molecules from myocardial tissue and restoring mitochondrial fatty acid metabolism.

Adults about 70 kg or more: Give approximately 100 mL of 20% lipid emulsion over 2 to 3 minutes, then infuse approximately 250 mL over 15 to 20 minutes .

Patients under 70 kg: Give 1.5 mL/kg over 2 to 3 minutes , then infuse 0.25 mL/kg/min .

Persistent instability: Repeat the bolus and double the infusion rate according to the ASRA checklist. Do not exceed a cumulative 12 mL/kg .

Modified ACLS Precautions:

Reduce Epinephrine Dosages: High-dose epinephrine worsens myocardial lactate production and arrhythmias; use small boluses of <1 mcg/kg (e.g., 10 to 100 mcg IV) .

Strictly Avoid: Vasopressin, calcium channel blockers, and beta-blockers.

Loading diagram... Local Anesthetic Systemic Toxicity (LAST) Emergency Clinical Protocol

Pneumatic Tourniquet Safety Protocols

Choose the correct cuff shape and width, inspect and pad the skin according to the device instructions, and prevent antiseptic solution from pooling beneath the cuff. Determine limb occlusion pressure (LOP) with the validated device when available and add the patient- and cuff-specific safety margin established by the manufacturer or facility policy. Use the lowest effective pressure rather than a routine fixed pressure based only on arm versus leg.

Document cuff location and size, skin condition, LOP when measured, selected pressure and rationale, inflation and deflation times, total duration, notifications, and post-deflation neurovascular and skin assessment. Minimize inflation time and notify the surgeon at facility-defined intervals. If prolonged use is unavoidable, the surgeon and anesthesia professional decide whether and when a reperfusion interval is appropriate based on the operation and patient; there is no single universal pressure, 60-minute alert schedule, or 120-minute maximum that replaces the IFU and clinical judgment.

Watch for cuff pain, nerve dysfunction, chemical injury, unexpected bleeding, hemodynamic change after inflation or deflation, and signs of thromboembolism. Resolve alarm conditions and never increase pressure reflexively without assessing cuff fit, position, LOP and equipment function.

Sedation Reversal Pharmacodynamics & Post-Reversal Nursing Care

When acute hypoventilation, apnea, or oversedation occurs during procedural sedation or MAC, the perioperative nurse must administer specific receptor antagonists under physician orders.

1. Naloxone Hydrochloride (Narcan) — Opioid Antagonist

Mechanism: Pure competitive antagonist at mu, kappa, and delta opioid receptors, instantly reversing opioid-induced respiratory depression, sedation, and analgesia.

Titrated Administration: Dilute an ampule of 0.4 mg naloxone in 9 mL of normal saline (yielding 0.04 mg/mL ). Administer 0.04 to 0.08 mg IV every 2 to 3 minutes slowly, titrating strictly until spontaneous respiratory effort resumes without completely abolishing surgical pain control.

Complications of Rapid Bolus: Pushing 0.4 mg undiluted causes an explosive hyperadrenergic surge: severe hypertension, tachycardia, ventricular arrhythmias, acute pulmonary edema, violent emergence agitation, and intractable surgical pain.

Duration of Action vs. Half-Life: Naloxone has a short half-life with a clinical duration of action of only 30 to 90 minutes . Most surgical opioids (fentanyl, morphine, hydromorphone) possess significantly longer half-lives ( 2 to 5 hours ). Consequently, naloxone clears the body while active opioid metabolites remain, leading to fatal secondary resedation . Any patient receiving naloxone must be monitored continuously for at least 2 hours post-administration .

2. Flumazenil (Romazicon) — Benzodiazepine Antagonist

Mechanism: Competitive antagonist at the benzodiazepine recognition site on the GABA-A receptor complex, reversing midazolam or diazepam sedation.

Administration: Initial dose of 0.2 mg IV administered over 15 to 30 seconds . If no clinical response occurs after 60 seconds, administer a second dose of 0.2 mg , repeatable at 60-second intervals up to a maximum cumulative dose of 1.0 mg .

Duration of Action: Onset occurs within 1 to 2 minutes; duration of action is 45 to 90 minutes , shorter than midazolam. Resedation monitoring is mandatory for at least 2 hours.

Black Box Contraindications:

Chronic Benzodiazepine Therapy: In patients taking chronic benzodiazepines for anxiety, insomnia, or seizure control, flumazenil precipitates severe, acute withdrawal and intractable, status epilepticus seizures that resist standard anticonvulsants.

Tricyclic Antidepressant Overdose: Concurrent ingestion increases fatal dysrhythmia risk.